Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019

Objective: Hyperamylasemia was found in a group of patients with COVID-19 during hospitalization. However, the evolution and the clinical significance of hyperamylasemia in COVID-19, is not well characterized. Design: In this retrospective cohort study, the epidemiological, demographic, laboratory,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ganxun, Liu, Tongtong, Jin, Guannan, Li, Tianhong, Liang, Junnan, Chen, Qian, Chen, Lin, Wang, Wei, Wang, Yuwei, Song, Jia, Liang, Huifang, Zhang, Chuanhan, Zhu, Peng, Zhang, Wanguang, Ding, Zeyang, Chen, Xiaoping, Zhang, Bixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580346/
https://www.ncbi.nlm.nih.gov/pubmed/34714255
http://dx.doi.org/10.18632/aging.203653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580346/
https://www.ncbi.nlm.nih.gov/pubmed/34714255
http://dx.doi.org/10.18632/aging.203653

Ejemplares similares